GEGG, Jr.; Colin V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for GEGG, Jr.; Colin V..The latest application filed is for "human cgrp receptor binding proteins".
- GEGG, Jr.; Colin V. - Camarillo CA
- Gegg, Jr.; Colin V. - Newbury Park CA
- Gegg, JR.; Colin V. - Newbury CA
| Patent | Date |
|---|---|
| Human Cgrp Receptor Binding Proteins App 20210179723 - BOONE; Thomas C. ; et al. | 2021-06-17 |
| Human Cgrp Receptor Binding Proteins App 20210179722 - BOONE; Thomas C. ; et al. | 2021-06-17 |
| Human Cgrp Receptor Binding Proteins App 20180142029 - BOONE; Thomas C. ; et al. | 2018-05-24 |
| Human CGRP receptor binding proteins Grant 9,862,771 - Boone , et al. January 9, 2 | 2018-01-09 |
| Fgf21 Mutants And Uses Thereof App 20160244497 - WALKER; Kenneth W. ; et al. | 2016-08-25 |
| FGF-21 mutants comprising polyethylene glycol and uses thereof Grant 9,279,013 - Walker , et al. March 8, 2 | 2016-03-08 |
| Human Cgrp Receptor Binding Proteins App 20150376286 - BOONE; Thomas C. ; et al. | 2015-12-31 |
| Human CGRP receptor binding proteins Grant 9,102,731 - Boone , et al. August 11, 2 | 2015-08-11 |
| Compositions And Methods For Producing Bioactive Fusion Proteins App 20130217625 - Walker; Kenneth W. ; et al. | 2013-08-22 |
| Compositions And Methods For Producing Bioactive Fusion Proteins App 20130209466 - WALKER; Kenneth W. ; et al. | 2013-08-15 |
| Compositions and methods for producing bioactive fusion proteins Grant 8,420,779 - Walker , et al. April 16, 2 | 2013-04-16 |
| Human CGRP Receptor Binding Proteins App 20130071410 - Boone; Thomas C. ; et al. | 2013-03-21 |
| CGRP peptide antagonists and conjugates Grant 8,168,592 - Gegg, Jr. , et al. May 1, 2 | 2012-05-01 |
| Thrombopoietic Compounds App 20110275122 - MIN; Hosung ; et al. | 2011-11-10 |
| DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression Grant 8,043,829 - Sullivan , et al. October 25, 2 | 2011-10-25 |
| Fgf21 Mutants And Uses Thereof App 20110195895 - Walker; Kenneth W. ; et al. | 2011-08-11 |
| Thrombopoietic compounds Grant 7,981,425 - Min , et al. July 19, 2 | 2011-07-19 |
| Methods of using conjugated toxin peptide therapeutic agents Grant 7,910,102 - Sullivan , et al. March 22, 2 | 2011-03-22 |
| DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression Grant 7,834,164 - Sullivan , et al. November 16, 2 | 2010-11-16 |
| Conjugated toxin peptide therapeutic agents Grant 7,820,623 - Sullivan , et al. October 26, 2 | 2010-10-26 |
| Human CGRP Receptor Binding Proteins App 20100172895 - Boone; Thomas C. ; et al. | 2010-07-08 |
| DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression App 20090305399 - Sullivan; John K. ; et al. | 2009-12-10 |
| Methods of using conjugated toxin peptide therapeutic agents App 20090297520 - Sullivan; John K. ; et al. | 2009-12-03 |
| DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression App 20090299044 - Sullivan; John K. ; et al. | 2009-12-03 |
| Conjugated toxin peptide therapeutic agents App 20090291885 - Sullivan; John K. ; et al. | 2009-11-26 |
| Use of alcohol co-solvents to improve pegylation reaction yields App 20090252703 - Gegg, JR.; Colin V. ; et al. | 2009-10-08 |
| Compositions and methods for producing bioactive fusion proteins App 20090118181 - Walker; Kenneth W. ; et al. | 2009-05-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 